Published in
Associação Brasileira de Psiquiatria - ABP, Revista Brasileira de Psiquiatria, 3(33), p. 223-224, 2011
DOI: 10.1590/s1516-44462011000300003
Links
- ORCID
- Associação Brasileira de Psiquiatria - ABP
- [www.scielo.br]
- [www.producao.usp.br] | PDF
- [www.researchgate.net] | PDF
Tools
Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia
Journal article published in 2011 by
Oliveira,João Paulo Maia De,
Machado de-Sousa,João Paulo,
João Paulo Maia de Oliveira,
Bruno Lobão,
Lobão,Bruno,
João Paulo Machado-De-Sousa 
,
Baker,Glen B.,
Glen B. Baker,
Serdar Dursun,
Dursun,Serdar,
Hallak,Jaime E. C.,
Jaime E. C. Hallak
,
Baker,Glen B.,
Glen B. Baker,
Serdar Dursun,
Dursun,Serdar,
Hallak,Jaime E. C.,
Jaime E. C. Hallak
This paper is made freely available by the publisher.
Full text: Download
Data provided by 